APO Research
Talk to an analyst

APO RESEARCH · REPORT

Femoral Cannula

Femoral arteriovenous cannula provides temporary support for extracorporeal circulation and gas exchange to replace heart or lung function as a bridge for resuscitation or other long-term support.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Femoral arteriovenous cannula provides temporary support for extracorporeal circulation and gas exchange to replace heart or lung function as a bridge for resuscitation or other long-term support.

When intubated through the femoral and internal jugular veins, blood is drawn through the femoral or internal jugular vein catheter and pumped through membrane oxygenators to remove carbon dioxide, increase oxygen, and provide temperature control.

Partial to complete extracorporeal lung support is provided to maintain adequate oxygenation and normal blood flow.

Selected research

Market Structure

Global Femoral Cannula Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025189 pages

Choose your research edition.

Industry ResearchFemoral Cannula Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Femoral Cannula Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Femoral Cannula Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Femoral Cannula Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Femoral Cannula Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Femoral arteriovenous cannula provides temporary support for extracorporeal circulation and gas exchange to replace heart or lung function as a bridge for resuscitation or other long-term support.

When intubated through the femoral and internal jugular veins, blood is drawn through the femoral or internal jugular vein catheter and pumped through membrane oxygenators to remove carbon dioxide, increase oxygen, and provide temperature control.

Partial to complete extracorporeal lung support is provided to maintain adequate oxygenation and normal blood flow.

Read the full market overview

Globally, major manufacturers of femoral arteriovenous systems include Medtronic, Edward Lifescience, LivaNova, Surge Cardiovascular, Kangxin, Xenios AG, and Chalice Medical.

The main producers are mainly in Europe and the United States.

This report provides an overview of the global Femoral Cannula market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Femoral Cannula and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Femoral Cannula sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Femoral Cannula market size, projected growth trends, production technologies, key applications, and end-use industries.

Femoral Cannula Segment by Company

Medtronic

Edward Lifescience

LivaNova

Surge Cardiovascular

Changzhou KangXin Medical Instruments Co., Ltd.

Chalice Medical Ltd.

Xenios AG

Femoral Cannula Segment by Type

Unipolar

Bipolar

Femoral Cannula Segment by Application

Traditional extracorporeal circulation surgery

Extracorporeal membrane oxygenation (ECMO)

Hemodialysis

Other

Femoral Cannula Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Femoral Cannula market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Femoral Cannula and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Femoral Cannula.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Femoral Cannula market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Femoral Cannula manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Femoral Cannula in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Femoral Cannula in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Femoral Cannula Industry Trends Table 2. Femoral Cannula Industry Drivers Table 3. Femoral Cannula Industry Opportunities and Challenges Table 4. Femoral Cannula Industry Restraints Table 5. Global Femoral Cannula Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Femoral Cannula Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Femoral Cannula Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Femoral Cannula Sales Market Share by Manufacturers Table 9. Global Femoral Cannula Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Femoral Cannula Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Femoral Cannula Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Femoral Cannula Manufacturers, Product Type & Application Table 13. Global Femoral Cannula Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Femoral Cannula by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Unipolar Table 17. Major Manufacturers of Bipolar Table 18. Global Femoral Cannula Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Femoral Cannula Sales by Type (2021-2026) & (K Units) Table 20. Global Femoral Cannula Sales by Type (2027-2032) & (K Units) Table 21. Global Femoral Cannula Sales Market Share by Type (2021-2026) Table 22. Global Femoral Cannula Sales Market Share by Type (2027-2032) Table 23. Global Femoral Cannula Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Femoral Cannula Revenue by Type (2021-2026) & (K Units) Table 25. Global Femoral Cannula Revenue by Type (2027-2032) & (K Units) Table 26. Global Femoral Cannula Revenue Market Share by Type (2021-2026) Table 27. Global Femoral Cannula Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Traditional extracorporeal circulation surgery Table 29. Major Manufacturers of Extracorporeal membrane oxygenation (ECMO) Table 30. Major Manufacturers of Hemodialysis Table 31. Major Manufacturers of Other Table 32. Global Femoral Cannula Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Femoral Cannula Sales by Application (2021-2026) & (K Units) Table 34. Global Femoral Cannula Sales by Application (2027-2032) & (K Units) Table 35. Global Femoral Cannula Sales Market Share by Application (2021-2026) Table 36. Global Femoral Cannula Sales Market Share by Application (2027-2032) Table 37. Global Femoral Cannula Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Femoral Cannula Revenue by Application (2021-2026) & (K Units) Table 39. Global Femoral Cannula Revenue by Application (2027-2032) & (K Units) Table 40. Global Femoral Cannula Revenue Market Share by Application (2021-2026) Table 41. Global Femoral Cannula Revenue Market Share by Application (2027-2032) Table 42. Global Femoral Cannula Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Femoral Cannula Sales by Region (2021-2026) & (K Units) Table 44. Global Femoral Cannula Sales Market Share by Region (2021-2026) Table 45. Global Femoral Cannula Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Femoral Cannula Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Femoral Cannula Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Femoral Cannula Sales by Country (2021-2026) & (K Units) Table 49. North America Femoral Cannula Sales by Country (2027-2032) & (K Units) Table 50. Europe Femoral Cannula Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Femoral Cannula Sales by Country (2021-2026) & (K Units) Table 52. Europe Femoral Cannula Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Femoral Cannula Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Femoral Cannula Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Femoral Cannula Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Femoral Cannula Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Femoral Cannula Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Femoral Cannula Sales by Country (2027-2032) & (K Units) Table 59. Global Femoral Cannula Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Femoral Cannula Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Femoral Cannula Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Femoral Cannula Revenue Market Share by Region (2021-2026) Table 63. Global Femoral Cannula Revenue Market Share by Region (2027-2032) Table 64. Medtronic Company Information Table 65. Medtronic Business Overview Table 66. Medtronic Femoral Cannula Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Medtronic Femoral Cannula Product Portfolio Table 68. Medtronic Recent Development Table 69. Edward Lifescience Company Information Table 70. Edward Lifescience Business Overview Table 71. Edward Lifescience Femoral Cannula Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Edward Lifescience Femoral Cannula Product Portfolio Table 73. Edward Lifescience Recent Development Table 74. LivaNova Company Information Table 75. LivaNova Business Overview Table 76. LivaNova Femoral Cannula Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. LivaNova Femoral Cannula Product Portfolio Table 78. LivaNova Recent Development Table 79. Surge Cardiovascular Company Information Table 80. Surge Cardiovascular Business Overview Table 81. Surge Cardiovascular Femoral Cannula Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Surge Cardiovascular Femoral Cannula Product Portfolio Table 83. Surge Cardiovascular Recent Development Table 84. Changzhou KangXin Medical Instruments Co., Ltd. Company Information Table 85. Changzhou KangXin Medical Instruments Co., Ltd. Business Overview Table 86. Changzhou KangXin Medical Instruments Co., Ltd. Femoral Cannula Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Changzhou KangXin Medical Instruments Co., Ltd. Femoral Cannula Product Portfolio Table 88. Changzhou KangXin Medical Instruments Co., Ltd. Recent Development Table 89. Chalice Medical Ltd. Company Information Table 90. Chalice Medical Ltd. Business Overview Table 91. Chalice Medical Ltd. Femoral Cannula Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Chalice Medical Ltd. Femoral Cannula Product Portfolio Table 93. Chalice Medical Ltd. Recent Development Table 94. Xenios AG Company Information Table 95. Xenios AG Business Overview Table 96. Xenios AG Femoral Cannula Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Xenios AG Femoral Cannula Product Portfolio Table 98. Xenios AG Recent Development Table 99. Key Raw Materials Table 100. Raw Materials Key Suppliers Table 101. Femoral Cannula Distributors List Table 102. Femoral Cannula Customers List Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Femoral Cannula Product Image Figure 2. Global Femoral Cannula Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Femoral Cannula Market Size (2021-2032) & (US$ Million) Figure 4. Global Femoral Cannula Sales (2021-2032) & (K Units) Figure 5. Global Femoral Cannula Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Femoral Cannula Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Unipolar Image Figure 9. Bipolar Image Figure 10. Global Femoral Cannula Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Femoral Cannula Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Femoral Cannula Sales Market Share by Type (2021-2032) Figure 13. Global Femoral Cannula Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Femoral Cannula Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Femoral Cannula Revenue Market Share by Type (2021-2032) Figure 16. Traditional extracorporeal circulation surgery Image Figure 17. Extracorporeal membrane oxygenation (ECMO) Image Figure 18. Hemodialysis Image Figure 19. Other Image Figure 20. Global Femoral Cannula Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Femoral Cannula Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Femoral Cannula Sales Market Share by Application (2021-2032) Figure 23. Global Femoral Cannula Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Femoral Cannula Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Femoral Cannula Revenue Market Share by Application (2021-2032) Figure 26. North America Femoral Cannula Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Femoral Cannula Sales Market Share by Country (2021-2032) Figure 28. U.S. Femoral Cannula Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Femoral Cannula Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Femoral Cannula Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Femoral Cannula Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Femoral Cannula Sales Market Share by Country (2021-2032) Figure 33. Germany Femoral Cannula Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Femoral Cannula Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Femoral Cannula Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Femoral Cannula Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Femoral Cannula Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Femoral Cannula Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Femoral Cannula Sales Market Share by Country (2021-2032) Figure 40. China Femoral Cannula Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Femoral Cannula Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Femoral Cannula Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Femoral Cannula Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Femoral Cannula Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Femoral Cannula Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Femoral Cannula Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Femoral Cannula Sales Market Share by Country (2021-2032) Figure 48. Brazil Femoral Cannula Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Femoral Cannula Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Femoral Cannula Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Femoral Cannula Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Femoral Cannula Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Femoral Cannula Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Femoral Cannula Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Femoral Cannula Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Femoral Cannula Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Femoral Cannula Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Femoral Cannula Revenue (2021-2032) & (US$ Million) Figure 59. North America Femoral Cannula Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Femoral Cannula Revenue (2021-2032) & (US$ Million) Figure 61. Europe Femoral Cannula Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Femoral Cannula Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Femoral Cannula Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Femoral Cannula Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Femoral Cannula Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Femoral Cannula Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Femoral Cannula Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Unipolar
  • Bipolar
Applications
  • Traditional extracorporeal circulation surgery
  • Extracorporeal membrane oxygenation (ECMO)
  • Hemodialysis
  • Other
Companies covered
  • Medtronic
  • Edward Lifescience
  • LivaNova
  • Surge Cardiovascular
  • Changzhou KangXin Medical Instruments Co., Ltd.
  • Chalice Medical Ltd.
  • Xenios AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Femoral Cannula Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Femoral Cannula Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Femoral Cannula Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Femoral Cannula Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Femoral Cannula Market Dynamics
  1. 2.1 Femoral Cannula Industry Trends
  2. 2.2 Femoral Cannula Industry Drivers
  3. 2.3 Femoral Cannula Industry Opportunities and Challenges
  4. 2.4 Femoral Cannula Industry Restraints
3 Femoral Cannula Market by Manufacturers
  1. 3.1 Global Femoral Cannula Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Femoral Cannula Sales by Manufacturers (2021-2026)
  3. 3.3 Global Femoral Cannula Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Femoral Cannula Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Femoral Cannula Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Femoral Cannula Manufacturers, Product Type & Application
  7. 3.7 Global Femoral Cannula Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Femoral Cannula Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Femoral Cannula Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Femoral Cannula Tier 1, Tier 2, and Tier 3
4 Femoral Cannula Market by Type
  1. 4.1 Femoral Cannula Type Introduction
  2. 4.1.1 Unipolar
  3. 4.1.2 Bipolar
  4. 4.2 Global Femoral Cannula Sales by Type
  5. 4.2.1 Global Femoral Cannula Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Femoral Cannula Sales by Type (2021-2032)
  7. 4.2.3 Global Femoral Cannula Sales Market Share by Type (2021-2032)
  8. 4.3 Global Femoral Cannula Revenue by Type
  9. 4.3.1 Global Femoral Cannula Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Femoral Cannula Revenue by Type (2021-2032)
  11. 4.3.3 Global Femoral Cannula Revenue Market Share by Type (2021-2032)
5 Femoral Cannula Market by Application
  1. 5.1 Femoral Cannula Application Introduction
  2. 5.1.1 Traditional extracorporeal circulation surgery
  3. 5.1.2 Extracorporeal membrane oxygenation (ECMO)
  4. 5.1.3 Hemodialysis
  5. 5.1.4 Other
  6. 5.2 Global Femoral Cannula Sales by Application
  7. 5.2.1 Global Femoral Cannula Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Femoral Cannula Sales by Application (2021-2032)
  9. 5.2.3 Global Femoral Cannula Sales Market Share by Application (2021-2032)
  10. 5.3 Global Femoral Cannula Revenue by Application
  11. 5.3.1 Global Femoral Cannula Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Femoral Cannula Revenue by Application (2021-2032)
  13. 5.3.3 Global Femoral Cannula Revenue Market Share by Application (2021-2032)
6 Global Femoral Cannula Sales by Region
  1. 6.1 Global Femoral Cannula Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Femoral Cannula Sales by Region (2021-2032)
  3. 6.2.1 Global Femoral Cannula Sales by Region (2021-2026)
  4. 6.2.2 Global Femoral Cannula Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Femoral Cannula Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Femoral Cannula Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Femoral Cannula Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Femoral Cannula Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Femoral Cannula Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Femoral Cannula Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Femoral Cannula Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Femoral Cannula Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Femoral Cannula Revenue by Region
  1. 7.1 Global Femoral Cannula Revenue by Region
  2. 7.1.1 Global Femoral Cannula Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Femoral Cannula Revenue by Region (2021-2026)
  4. 7.1.3 Global Femoral Cannula Revenue by Region (2027-2032)
  5. 7.1.4 Global Femoral Cannula Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Femoral Cannula Revenue (2021-2032)
  8. 7.2.2 North America Femoral Cannula Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Femoral Cannula Revenue (2021-2032)
  11. 7.3.2 Europe Femoral Cannula Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Femoral Cannula Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Femoral Cannula Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Femoral Cannula Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Femoral Cannula Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Medtronic
  2. 8.1.1 Medtronic Company Information
  3. 8.1.2 Medtronic Business Overview
  4. 8.1.3 Medtronic Femoral Cannula Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Medtronic Femoral Cannula Product Portfolio
  6. 8.1.5 Medtronic Recent Developments
  7. 8.2 Edward Lifescience
  8. 8.2.1 Edward Lifescience Company Information
  9. 8.2.2 Edward Lifescience Business Overview
  10. 8.2.3 Edward Lifescience Femoral Cannula Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Edward Lifescience Femoral Cannula Product Portfolio
  12. 8.2.5 Edward Lifescience Recent Developments
  13. 8.3 LivaNova
  14. 8.3.1 LivaNova Company Information
  15. 8.3.2 LivaNova Business Overview
  16. 8.3.3 LivaNova Femoral Cannula Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 LivaNova Femoral Cannula Product Portfolio
  18. 8.3.5 LivaNova Recent Developments
  19. 8.4 Surge Cardiovascular
  20. 8.4.1 Surge Cardiovascular Company Information
  21. 8.4.2 Surge Cardiovascular Business Overview
  22. 8.4.3 Surge Cardiovascular Femoral Cannula Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Surge Cardiovascular Femoral Cannula Product Portfolio
  24. 8.4.5 Surge Cardiovascular Recent Developments
  25. 8.5 Changzhou KangXin Medical Instruments Co., Ltd.
  26. 8.5.1 Changzhou KangXin Medical Instruments Co., Ltd. Company Information
  27. 8.5.2 Changzhou KangXin Medical Instruments Co., Ltd. Business Overview
  28. 8.5.3 Changzhou KangXin Medical Instruments Co., Ltd. Femoral Cannula Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Changzhou KangXin Medical Instruments Co., Ltd. Femoral Cannula Product Portfolio
  30. 8.5.5 Changzhou KangXin Medical Instruments Co., Ltd. Recent Developments
  31. 8.6 Chalice Medical Ltd.
  32. 8.6.1 Chalice Medical Ltd. Company Information
  33. 8.6.2 Chalice Medical Ltd. Business Overview
  34. 8.6.3 Chalice Medical Ltd. Femoral Cannula Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Chalice Medical Ltd. Femoral Cannula Product Portfolio
  36. 8.6.5 Chalice Medical Ltd. Recent Developments
  37. 8.7 Xenios AG
  38. 8.7.1 Xenios AG Company Information
  39. 8.7.2 Xenios AG Business Overview
  40. 8.7.3 Xenios AG Femoral Cannula Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Xenios AG Femoral Cannula Product Portfolio
  42. 8.7.5 Xenios AG Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Femoral Cannula Value Chain Analysis
  2. 9.1.1 Femoral Cannula Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Femoral Cannula Production Mode & Process
  6. 9.2 Femoral Cannula Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Femoral Cannula Distributors
  9. 9.2.3 Femoral Cannula Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst